business / news / / The Economic Times
This will also be the largest overseas purchase by an Indian company after Corus was taken over by Tata Steel in April 2007.
Sun Pharmaceutical is set to acquire Organon & Co for approximately $12.5 billion in its biggest deal.
KEY POINTS
- Sun will pay $4.5 billion in equity and assume Organon's $8.5 billion debt in the transaction.
- Organon's board selected Sun over a rival EQT-Grünenthal consortium as the preferred bidder.
- Sun Pharma incorporated Sun Pharma America Inc. on Friday, likely as the acquisition vehicle for this deal.
- Aalok Shanghvi, executive chairman’s son, is expected to relocate to the US post-acquisition completion.
COMPANIES
Summarized by Newsio from The Economic Times. How we summarize →